Adverse Event Reports from Metabolife

Thumbnail Image
Files
2002-10-08_R-Adverse_Event_Reports_from_Metabolife-107C.pdf (275.23 KB)
Serial Number
Levin Center Identifier
OR.107.58
Document Date
2002-10-08
Report Length
23 pages
Policy Agendas Project Major Code
3: Health
Policy Agendas Project Minor Code
321: Regulation of Drug Industry, Medical Devices, and Clinical Labs
Additional, Minority, Dissenting Views
Report Type
Committee Minority Staff Report
Found Using Methodology
Committee(s)
House Committee on Government Reform
Subcommittee(s)
Special Investigations Division
Commission(s)
Idependent Author(s)
Brief Executive Summary
The Special Investigations Division of the House Committee on Government Reform conducted an investigation into Metabolife, the country's largest manufacturer of dietary supplements containing ephedra, and the consumer safety of the company's products. The committee examined over 13,000 reports that the company had received between 1997 and 2002 warning of adverse effects caused by the company's products. The committee found that Metabolife carelessly ignored these consumer reports and routinely failed to obtain necessary medical records to determine its product safety.
Press Releases and Contextual Information
Related Hearings
Authors–Congress Members
Authors–Staff Members
Authors–Ex Officio Members
Authors–Additional, Minority, Dissenting Views
Citation
URI
https://hdl.handle.net/20.500.14300/971
Collections
House Committee on Oversight and Accountability